Document is current
Any future updates will be listed below
-
Authors
Xiao, Congmei
Chen, Qian
Shuai, Menglei
Gao, Chang
Gou, Wanglong
Miao, Zelei
Zhang, Ke
Shen, Luqi
Liang, Xinxiu
Wang, Chun
Zhong, Haili
Ye, Meng
Xu, Fengzhe
Tang, Jun
Jiang, Zengliang
Xi, Yue
Fu, Yuanqing
Chen, Yu-ming
Zheng, Ju-Sheng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82073546, 92374112, 82073529, 82103826,82103828)
'Pioneer' and 'Leading goose' R&D Program of Zhejiang (2023C02044)
Zhejiang Provincial Key Laboratory Construction Project (2024ZY01026)
the Research Program of Westlake Laboratory of Life Sciences and Biomedicine (202208012)
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 30 July 2025
First Online: 8 August 2025
Declarations
:
: The GNHS and WeBirth were approved by the Ethics Committee of Westlake University (approval numbers: 20190114ZJS0003 and 20190701ZJS0007). The GNHS was also approved by the Ethics Committee of the School of Public Health at Sun Yat-sen University (approval number: 2018048). Both cohorts were registered at clinicaltrials.gov, with the registration numbers: NCT03179657 for GNHS and NCT04060056 for WeBirth. The written informed consent was obtained for all participants.
: Not applicable.
: The authors declare that they have no competing interests.
